Potassium chloride NDC 33342-417

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-417Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0417Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
33342-417-11	33342041711	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (33342-417-11)Marketed from Sep 8, 2024
33342-417-12	33342041712	10 BLISTER PACK in 1 CARTON (33342-417-12) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Sep 8, 2024
33342-417-15	33342041715	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (33342-417-15)Marketed from Sep 8, 2024
33342-417-34	33342041734	10 BLISTER PACK in 1 CARTON (33342-417-34) / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMarketed from Sep 8, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 600 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212987
Marketing start: Sep 8, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 33342-417_e0562a05-4359-4256-87e3-fcde65a008cdSPL ID e0562a05-4359-4256-87e3-fcde65a008cdSPL set ID e0562a05-4359-4256-87e3-fcde65a008cdRxCUI 312529, 628953UNII 660YQ98I10UPC 0333342417114, 0333342418111, 0333342418159, 0333342417152
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342041711 followed by a unit qualifier and the quantity

Package 33342-0417-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 18, 2025.

Indications (excerpt from the label)

Potassium chloride extended-release tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium chloride extended-release tablets is a potassium salt, indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212987

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212987
Product	Strength	Form · route	Labeler	Product NDC
Potassium chloride	Potassium chloride 750 mg/1	Tablet, Film coated, Extended releaseOral	Macleods Pharmaceuticals Limited	33342-418